http://rdf.disgenet.org/resource/nanopub/NP563079.RALOqEG1vuHhM3t9efhUdmJx0EH9x2t2iVUS5BAFnqGUg#head
http://rdf.disgenet.org/resource/nanopub/NP563079.RALOqEG1vuHhM3t9efhUdmJx0EH9x2t2iVUS5BAFnqGUg
http://www.nanopub.org/nschema#hasAssertion
http://rdf.disgenet.org/resource/nanopub/NP563079.RALOqEG1vuHhM3t9efhUdmJx0EH9x2t2iVUS5BAFnqGUg#assertion
http://rdf.disgenet.org/resource/nanopub/NP563079.RALOqEG1vuHhM3t9efhUdmJx0EH9x2t2iVUS5BAFnqGUg
http://www.nanopub.org/nschema#hasProvenance
http://rdf.disgenet.org/resource/nanopub/NP563079.RALOqEG1vuHhM3t9efhUdmJx0EH9x2t2iVUS5BAFnqGUg#provenance
http://rdf.disgenet.org/resource/nanopub/NP563079.RALOqEG1vuHhM3t9efhUdmJx0EH9x2t2iVUS5BAFnqGUg
http://www.nanopub.org/nschema#hasPublicationInfo
http://rdf.disgenet.org/resource/nanopub/NP563079.RALOqEG1vuHhM3t9efhUdmJx0EH9x2t2iVUS5BAFnqGUg#publicationInfo
http://rdf.disgenet.org/resource/nanopub/NP563079.RALOqEG1vuHhM3t9efhUdmJx0EH9x2t2iVUS5BAFnqGUg
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://rdf.disgenet.org/resource/nanopub/NP563079.RALOqEG1vuHhM3t9efhUdmJx0EH9x2t2iVUS5BAFnqGUg#assertion
http://rdf.disgenet.org/resource/gda/DGN7200310feddc39592efc2c5f01c2ce0f
http://semanticscience.org/resource/SIO_000628
http://identifiers.org/ncbigene/3558
http://rdf.disgenet.org/resource/gda/DGN7200310feddc39592efc2c5f01c2ce0f
http://semanticscience.org/resource/SIO_000628
http://linkedlifedata.com/resource/umls/id/C0019693
http://rdf.disgenet.org/resource/gda/DGN7200310feddc39592efc2c5f01c2ce0f
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://semanticscience.org/resource/SIO_001122
http://rdf.disgenet.org/resource/nanopub/NP563079.RALOqEG1vuHhM3t9efhUdmJx0EH9x2t2iVUS5BAFnqGUg#provenance
http://rdf.disgenet.org/resource/nanopub/NP563079.RALOqEG1vuHhM3t9efhUdmJx0EH9x2t2iVUS5BAFnqGUg#assertion
http://purl.org/dc/terms/description
[To evaluate the safety and efficacy of 3 regimens of intermittent subcutaneous (sc) interleukin (IL)--2 in a phase 2 study, 61 antiviral drug-experienced human immunodeficiency virus (HIV)--positive patients were randomly assigned to one of the following study arms: antiretroviral therapy (ART) plus IL-2 (12 million IU [MIU] by continuous intravenous infusion, followed by 7.5 MIU twice a day, sc, every 8 weeks); ART plus IL-2 (7.5 MIU twice a day, sc, every 8 weeks); ART plus IL-2 (3 MIU twice a day, sc, every 4 weeks); or ART alone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
http://rdf.disgenet.org/resource/nanopub/NP563079.RALOqEG1vuHhM3t9efhUdmJx0EH9x2t2iVUS5BAFnqGUg#assertion
http://purl.org/ontology/wi/core#evidence
http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature
http://rdf.disgenet.org/resource/nanopub/NP563079.RALOqEG1vuHhM3t9efhUdmJx0EH9x2t2iVUS5BAFnqGUg#assertion
http://semanticscience.org/resource/SIO_000772
http://identifiers.org/pubmed/11319683
http://rdf.disgenet.org/resource/nanopub/NP563079.RALOqEG1vuHhM3t9efhUdmJx0EH9x2t2iVUS5BAFnqGUg#assertion
http://www.w3.org/ns/prov#wasDerivedFrom
http://rdf.disgenet.org/v5.0.0/void/BEFREE
http://rdf.disgenet.org/resource/nanopub/NP563079.RALOqEG1vuHhM3t9efhUdmJx0EH9x2t2iVUS5BAFnqGUg#assertion
http://www.w3.org/ns/prov#wasGeneratedBy
http://purl.obolibrary.org/obo/ECO_0000203
http://rdf.disgenet.org/v5.0.0/void/BEFREE
http://purl.org/pav/importedOn
2017-02-19
http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.obolibrary.org/obo/ECO_0000212
http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature
http://www.w3.org/2000/01/rdf-schema#comment
Gene-disease associations inferred from text-mining the literature.
http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature
http://www.w3.org/2000/01/rdf-schema#label
DisGeNET evidence - LITERATURE
http://rdf.disgenet.org/resource/nanopub/NP563079.RALOqEG1vuHhM3t9efhUdmJx0EH9x2t2iVUS5BAFnqGUg#publicationInfo
http://rdf.disgenet.org/resource/nanopub/NP563079.RALOqEG1vuHhM3t9efhUdmJx0EH9x2t2iVUS5BAFnqGUg
http://purl.org/dc/terms/created
2017-10-17T13:13:46+02:00
http://rdf.disgenet.org/resource/nanopub/NP563079.RALOqEG1vuHhM3t9efhUdmJx0EH9x2t2iVUS5BAFnqGUg
http://purl.org/dc/terms/rights
http://opendatacommons.org/licenses/odbl/1.0/
http://rdf.disgenet.org/resource/nanopub/NP563079.RALOqEG1vuHhM3t9efhUdmJx0EH9x2t2iVUS5BAFnqGUg
http://purl.org/dc/terms/rightsHolder
http://rdf.disgenet.org/v5.0.0/void/IBIGroup
http://rdf.disgenet.org/resource/nanopub/NP563079.RALOqEG1vuHhM3t9efhUdmJx0EH9x2t2iVUS5BAFnqGUg
http://purl.org/dc/terms/subject
http://semanticscience.org/resource/SIO_000983
http://rdf.disgenet.org/resource/nanopub/NP563079.RALOqEG1vuHhM3t9efhUdmJx0EH9x2t2iVUS5BAFnqGUg
http://purl.org/net/provenance/ns#usedData
http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf
http://rdf.disgenet.org/resource/nanopub/NP563079.RALOqEG1vuHhM3t9efhUdmJx0EH9x2t2iVUS5BAFnqGUg
http://purl.org/pav/authoredBy
http://orcid.org/0000-0001-5999-6269
http://rdf.disgenet.org/resource/nanopub/NP563079.RALOqEG1vuHhM3t9efhUdmJx0EH9x2t2iVUS5BAFnqGUg
http://purl.org/pav/authoredBy
http://orcid.org/0000-0002-7534-7661
http://rdf.disgenet.org/resource/nanopub/NP563079.RALOqEG1vuHhM3t9efhUdmJx0EH9x2t2iVUS5BAFnqGUg
http://purl.org/pav/authoredBy
http://orcid.org/0000-0002-9383-528X
http://rdf.disgenet.org/resource/nanopub/NP563079.RALOqEG1vuHhM3t9efhUdmJx0EH9x2t2iVUS5BAFnqGUg
http://purl.org/pav/authoredBy
http://orcid.org/0000-0003-0169-8159
http://rdf.disgenet.org/resource/nanopub/NP563079.RALOqEG1vuHhM3t9efhUdmJx0EH9x2t2iVUS5BAFnqGUg
http://purl.org/pav/authoredBy
http://orcid.org/0000-0003-1244-7654
http://rdf.disgenet.org/resource/nanopub/NP563079.RALOqEG1vuHhM3t9efhUdmJx0EH9x2t2iVUS5BAFnqGUg
http://purl.org/pav/createdBy
http://orcid.org/0000-0003-0169-8159
http://rdf.disgenet.org/resource/nanopub/NP563079.RALOqEG1vuHhM3t9efhUdmJx0EH9x2t2iVUS5BAFnqGUg
http://purl.org/pav/version
v5.0.0.0
http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf
http://purl.org/pav/version
v5.0.0